According to reports from Mint, Nifty50 currently trades at 18.4x forward PE, indicating that valuations remain elevated even after a marginal cooldown. The market shows significant sectoral variations, with Pharma emerging as the priciest large-cap bet at 33.8x forward PE, while IT sector has undergone sharp re-rating to 17.3x forward PE. Despite these elevated levels, the market demonstrated strong earnings performance in Q1FY27.
As reported by Mint, Nifty50 Q1FY27 EPS grew a strong 12.9% YoY, significantly outperforming the 4.5% estimate. This broad-based strength was primarily driven by mid and small-cap segments, indicating robust earnings momentum across the broader market. The strong earnings growth suggests underlying business fundamentals remain resilient despite current valuation concerns.
According to Mint, Venkatesh Balasubramaniam, MD & Head of Research at JM Financial Institutional Securities, has identified several attractive investment opportunities. HAL and BEL valuations still look attractive for defence sector exposure, while MTAR Technologies gets initiated with a large BUY rating. Additionally, Data Patterns is also recommended as a BUY, suggesting a diversified approach across technology and defence sectors.
As reported by Mint, Balasubramaniam emphasizes that banks aren't a rush-to-buy yet despite the current market conditions. The focus should remain on domestic earnings visibility across infra, auto and consumer names, indicating a preference for sectors with clear growth visibility and domestic market exposure. This strategy suggests a cautious approach to traditional banking investments while maintaining interest in sectors with strong fundamentals.
